Ads
related to: chronic lymphoma leukemia prognosis life expectancy table- Resources For HCPs
Access Resources & See How You
May Help Your R/R CLL/SLL Patients.
- Dosing & Admin Info
Review Dosing & Administration
Info On The Official HCP Site.
- Resources For HCPs
Search results
Results from the WOW.Com Content Network
Watchful waiting, chemotherapy, immunotherapy [4] [5] Prognosis. Five-year survival ~88% (US) [3] Frequency. 904,000 (2015) [6] Deaths. 60,700 (2015) [7] Chronic lymphocytic leukemia ( CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell ). [2] [8] Early on, there are typically no symptoms. [2]
Prognosis. The 5 year survival has been noted as 89% in at least one study from France of 201 patients with T-LGL leukemia. Epidemiology. T-LGLL is a rare form of leukemia, comprising 2-3% of all cases of chronic lymphoproliferative disorders. [citation needed] History
About 1-10% of CLL/SLLs develop a Richter's transformation at a rate of 0.5–1% per year. In earlier studies, the transformed disease was reported to be far more aggressive than CLL/SLL with overall median survival times (i.e. times in which 50% of cases remain alive) between 1.1 and 16.3 months.
Infectious mononucleosis, acute myeloid leukemia, lymphoblastic lymphoma, aplastic anemia: Treatment: Chemotherapy, stem cell transplantation, radiation therapy, targeted therapy: Prognosis: Children: 90% five-year survival rate Adults: 35% five-year survival: Frequency: 1 in 1,750 children: Deaths: 111,000 (2015)
A 2006 follow-up of 553 patients using imatinib (Gleevec) found an overall survival rate of 89% after five years. [32] A 2011 followup of 832 patients using imatinib who achieved a stable cytogenetic response found an overall survival rate of 95.2% after 8 years, which is similar to the rate in the general population.
Expected survival upon diagnosis of acute myeloid leukemia in the United States Chromosomal translocation (9;11), associated with AML. Multiple factors influence prognosis in AML, including the presence of specific mutations, and a person with AML's age.
Ads
related to: chronic lymphoma leukemia prognosis life expectancy table